Table 2.
Changes in BCVA and CMT of each group.
| Baseline CMT | 250μm-300μm | 300μm - 500μm | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Natural course (n=28) | Natural course (n=17) | IVTA (n=15) | Laser (n=16) | p-value* | |||||
| BCVA (logMAR) | p-value† | p-value† | p-value† | p-value† | |||||
| Baseline | 0.32±0.27 | 0.61±0.41 | 0.71±0.45 | 0.58±0.36 | 0.643 | ||||
| 1 month | 0.35±0.34 | 0.741 | 0.62±0.38 | 0.906 | 0.48±0.28 | 0.097 | 0.55±0.38 | 0.817 | 0.508 |
| 3 months | 0.30±0.24 | 0.713 | 0.59±0.56 | 0.924 | 0.48±0.24 | 0.089 | 0.59±0.35 | 0.937 | 0.691 |
| 6 months | 0.28±0.24 | 0.533 | 0.55±0.53 | 0.718 | 0.52±0.36 | 0.218 | 0.67±0.45 | 0.556 | 0.649 |
| CMT (μm) | |||||||||
| Baseline | 274.14±16.95 | 374.94±62.03 | 416.80±38.00 | 378.00±53.62 | 0.058 | ||||
| 1 month | 287.54±47.92 | 0.172 | 318.88±82.17 | 0.032 | 290.40±70.48 | 0.000 | 307.31±93.76 | 0.014 | 0.627 |
| 3 months | 296.79±79.10 | 0.149 | 304.00±65.09 | 0.003 | 275.40±93.24 | 0.000 | 297.00±113.86 | 0.018 | 0.668 |
| 6 months | 283.75±69.03 | 0.480 | 284.18±80.84 | 0.001 | 310.33±103.28 | 0.002 | 285.69±115.76 | 0.009 | 0.720 |
IVTA: intravitreal injection of triamcinolone acetonide; BCVA: best corrected visual acuity; CMT: central macular thickness
*Kruskal-Wallis test (p<0.05)
†Wilcoxon Matched-Pairs Signed-Ranks test (p<0.05)
: baseline - 1 month, baseline - 3 months, baseline - 6 months